L. Adamek
- Prevalence of asthma control among adults in France, Germany, Italy, Spain and the UKBy P. Demoly, P. Paggiaro, V. Plaza, S. C. Bolge, H. Kannan, B. Sohier and L. AdamekP. DemolyP. PaggiaroV. PlazaS. C. BolgeH. KannanB. Sohier
- Update on asthma control in five European countries: results of a 2008 surveyBy P. Demoly, B. Gueron, K. Annunziata, L. Adamek and R. D. WaltersP. DemolyB. GueronK. AnnunziataL. Adamek
- Repeated cross-sectional survey of patient-reported asthma control in Europe in the past 5 yearsBy P. Demoly, K. Annunziata, E. Gubba and L. AdamekP. Demoly*Allergy Division, Pneumology Dept, INSERM U657, Hôpital Arnaud de Villeneuve, University Hospital of Montpellier, Montpellier, France. #Kantar Health, Princeton, NJ, USA. ¶Post Synaptic Ltd, London, and +GlaxoSmithKline, Respiratory Centre of Excellence, Uxbridge, UK.K. Annunziata*Allergy Division, Pneumology Dept, INSERM U657, Hôpital Arnaud de Villeneuve, University Hospital of Montpellier, Montpellier, France. #Kantar Health, Princeton, NJ, USA. ¶Post Synaptic Ltd, London, and +GlaxoSmithKline, Respiratory Centre of Excellence, Uxbridge, UK.E. Gubba*Allergy Division, Pneumology Dept, INSERM U657, Hôpital Arnaud de Villeneuve, University Hospital of Montpellier, Montpellier, France. #Kantar Health, Princeton, NJ, USA. ¶Post Synaptic Ltd, London, and +GlaxoSmithKline, Respiratory Centre of Excellence, Uxbridge, UK.L. Adamek*Allergy Division, Pneumology Dept, INSERM U657, Hôpital Arnaud de Villeneuve, University Hospital of Montpellier, Montpellier, France. #Kantar Health, Princeton, NJ, USA. ¶Post Synaptic Ltd, London, and +GlaxoSmithKline, Respiratory Centre of Excellence, Uxbridge, UK.
- Properties of the COPD assessment test in a cross-sectional European studyBy P.W. Jones, G. Brusselle, R.W. Dal Negro, M. Ferrer, P. Kardos, M.L. Levy, T. Perez, J.J. Soler Cataluña, T. van der Molen, L. Adamek and N. BanikP.W. JonesG. BrusselleR.W. Dal NegroM. FerrerP. KardosM.L. LevyT. PerezJ.J. Soler CataluñaT. van der MolenL. Adamek
- Genetic polymorphisms associated with acute pulmonary embolism and deep venous thrombosisBy E. Nizankowska-Mogilnicka, L. Adamek, P. Grzanka, T.B. Domagala, M. Sanak, M. Krzanowski and A. SzczeklikE. Nizankowska-MogilnickaL. AdamekP. GrzankaT.B. DomagalaM. SanakM. Krzanowski
- Distribution of COPD patients in the GOLD assessment framework by exacerbationsBy G. Nadeau, L. Adamek and M. SmallG. Nadeau1Respiratory Center of Excellence, GSK, Uxbridge, United KingdomL. Adamek1Respiratory Center of Excellence, GSK, Uxbridge, United KingdomM. Small2Adelphi Real World, Adelphi Group, Macclesfield, United Kingdom
- Metabolic and cardiovascular comorbidity in COPD patients classified using the GOLD 2011 assessment frameworkBy P.W. Jones, G. Nadeau, M. Small and L. AdamekP.W. Jones1Clinical Sciences, St-George's University London, London, United KingdomG. Nadeau2Respiratory Center of Excellence, GSK, Uxbridge, Middlesex, United KingdomM. Small3Adelphi Real World, Adelphi Group, Macclesfield, United KingdomL. Adamek2Respiratory Center of Excellence, GSK, Uxbridge, Middlesex, United Kingdom
- Distribution of a COPD population based on the GOLD assessment frameworkBy G. Nadeau, P.W. Jones, L. Adamek and M. SmallG. Nadeau1Respiratory Centre of Excellence, GSK, Uxbridge, United KingdomP.W. Jones2Clinical Science, St George's, University of London, United KingdomL. Adamek1Respiratory Centre of Excellence, GSK, Uxbridge, United KingdomM. Small3Adelphi Real World, Adelphi Group, Macclesfield, United Arab Emirates
- Properties of the COPD Assessment Test (CAT) in a cross-sectional European studyBy P.W. Jones, G. Brusselle, R.W. Dal Negro, M. Ferrer, P. Kardos, M.L. Levy, T. Perez, J.J. Soler Cataluña, T. van der Molen, L. Adamek and N. BanikArticle | Published in 2011 in European Respiratory JournalP.W. JonesG. BrusselleR.W. Dal NegroM. FerrerP. KardosM.L. LevyT. PerezJ.J. Soler CataluñaT. van der MolenL. Adamek
- Comparisons of health status scores with MRC grades in a primary care COPD population: implications for the new GOLD 2011 classificationBy PW Jones, L. Adamek, G Nadeau and N. BanikArticle | Published in 2012 in European Respiratory JournalPW Jones*Division of Clinical Science, St George's, University of London, UKL. Adamek#Respiratory Centre of Excellence, GlaxoSmithKline, Uxbridge, United KingdomG Nadeau#Respiratory Centre of Excellence, GlaxoSmithKline, Uxbridge, United KingdomN. Banik¶Biostatistics and Epidemiology, GlaxoSmithKline, Munich, Germany
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.